The Paul-Bunnell Heterophile Antibody Determinant in Epstein-Barr Virus-Associated Disease

References

• Abiko T, Kumikawa M, Sekino H: Inhibition effect of rosette formation between hu-man lymphocytes and sheep erythrocytes by specific heptapeptide isolated form uremic fluid and its analogs. Biochemical and Biophysical Research Communica-tions 86: 945–952, 1979.
   PubMed Web of Science ®Google Scholar
• Ablashi DV, Levine PH, De Vinci C, Whitman JE Jr, Pizza G, Viza D: The use of anti-HHV-6 transfer factor for the treatment of two patients with chronic fatigue syn-drome (CFS). Two case reports. Biotherapy 9 (1–3): 81–86, 1996.
   Google Scholar
• Ablashi DV, Handy M, Bernbaum J, Chatlyne LG, Lapps W, Kramarsky B, Berneman ZN, Komaroff AL, Whitman JE: Propagation and characterization of human herpes-virus-7 (HHV-7) isolates in a continuous T-Iymphoblastoid cell line (SUPT1). Jour-nal of Virological Methods 73 (2): 123–140, 1998.
   Google Scholar
• Abo W, Kamada M, Motoya T, et al.: Evolution of infectious mononucleosis into Ep-stein-Barr virus carrying monoclonal malignant lymphoma. Lancet 1: 1272–1276, 1982.
   PubMed Web of Science ®Google Scholar
• Al-Jitawi SA, Hakooz BA, Kazimi SM: False-positive Monospot test in systemic lupus erythematosus. British Journal of Rheumatology 26: 71, 1987.
   PubMedGoogle Scholar
• Alcover A, Ramarli D, Richardson NE, Chang H-C, Rienherz EL: Functional and mo-lecular aspects of human T lymphocyte activation via T3-Ti and T11 pathways. Im-munology Reviews 95: 5–36, 1987.
   PubMed Web of Science ®Google Scholar
• Bach JF, Dormant J, Dardenne M, Bainer H: In vitro rosette inhibition by antihuman antilymphocyte serum. Transplantation 8: 265–280, 1969.
   PubMed Web of Science ®Google Scholar
• Bahna SL, Heiner DC, Horwitz CA: Sequential changes of the five immunoglobulin classes and other responses in infectious mononucleosis. International Archives of Applied Immunology 74: 1–8, 1994.
   Google Scholar
• Bailey GH, Raffel S: Hemolytic antibodies for sheep and ox erythrocytes in infectious mononucleosis. Journal of Clinical Investigation 14: 228–244, 1935.
   PubMedGoogle Scholar
• Basson V, Sharp A: Monospot: a differential slide test for infectious mononucleosis. Journal of Clinical Pathology 22: 324–325, 1969.
   PubMed Web of Science ®Google Scholar
• Beer P: The heterophile antibodies in infectious mononucleosis and after the injection of serum. Journal of Clinical Investigation 15: 591–599, 1936.
   PubMedGoogle Scholar
• Bennett BK, Hickie IB, Vollmer-Conna US, Quigley B, Brennan CM, Wakefield D, Douglas MP, Hansen GR, Tahmindjis AJ, Lloyd AR: The relationship between fa-tigue, psychological and immunological variables in acute infectious illness. Aus-tralian & New Zealand Journal of Psychiatry 32 (2): 180–186, 1998.
   PubMed Web of Science ®Google Scholar
• Berlin BS: Infectious mononucleosis. In: The Biologic, and Clinical Basis of Infectious Diseases. Youman, Paterson and Sinners, Eds., W.B. Saunders, Philadelphia, 1980.
   Google Scholar
• Bernard A, Aubrit F, Raynal B, Pham D, Bomsell L: A T cell surface molecule differ-ent from CD2 is involved in spontaneous rosette formation with erythrocytes. Jour-nal of Immunology 140: 1802–1807, 1996.
   Google Scholar
• Bernard A, Tran HC, Boumsell L: Three different erythrocyte surface molecules are required for spontaneous T cell rosette formation. Journal of Immunology 139: 18–23, 1988.
   Web of Science ®Google Scholar
• Boldt DH, Armstrong JP: Rosette formation between human lymphocytes and sheep erythrocytes: inhibition of rosette formation by specific glycopeptides. Journal of Clinical Investigation 57: 1068–1078, 1976.
   PubMed Web of Science ®Google Scholar
• Brain P, Gordon J, Willetts WA: Rosette formation by peripheral lymphocytes. Clini-cal and Experimental Immunology 6: 681–688, 1970.
   PubMed Web of Science ®Google Scholar
• Braun DK, Dominguez G, Pellett PE: Human herpesvirus 6. Clinical Microbiology Reviews 10 (3): 521–567, 1997.
   Google Scholar
• Brottier P, Boumsell L, Gelin C, Bernard A: T cell activation via CD2 (T, gp50) mole-cules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11 (1) epitopes. Journal of Immunology 135: 1624–1631, 1985.
   Google Scholar
• Brown MH, Krissnasen GW, Totty NF, Sewell WA, Crumpton Mk Purification and N-terminal amino acid sequence of the human T lymphocyte CD2 (T11) surface an-tigen. European Journal of Immunology 17: 15–20, 1987.
   PubMed Web of Science ®Google Scholar
• Buchwald D, Ashley RL, Pearlman T, Kith P, Komaroff AL: Viral serologies in pa-tients with chronic fatigue and chronic fatigue syndrome. Journal of Medical Virol-ogy 50 (1): 25–30, 1996.
   PubMed Web of Science ®Google Scholar
• Caldwell KE: Structure-function correlation among some erythrocyte membrane sialo-glycoproteins. PhD thesis, University of Miami, 1989.
   Google Scholar
• Cantani A, Mastrantoni F: Recent advances on Epstein-Barr virus infectious mononu-cleosis. Revista Europea per le Scienze Mediche e Farmacologiche 11(1): 41–44, 1989.
   PubMedGoogle Scholar
• Chang H-C, Moingeon P, Pedersen R, Lucich J, Stebbins C, Reinherz EL: Involvement of the PPPGHR motif in T cell activation via CD2. Journal of Experimental Medi-cine 172: 351–355, 1990.
   PubMed Web of Science ®Google Scholar
• Chisari FV, Edgington TS: Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein. Journal of Experimental Medicine 142: 1092–1105, 1975.
   PubMed Web of Science ®Google Scholar
• Chisari FV, Gealy WJ, Edgington TS: Recovery of soluble sheep erythrocyte receptor from the T lymphocyte surface by proteolytic cleavage. Journal of Immunology 118: 1138–1142, 1977.
   PubMed Web of Science ®Google Scholar
• Clayton LK, Sayre PH, Novotny J, Reinherz EL: Murine and human T11 (CD2) cDNA sequences suggest a common signal transduction mechanism. European Journal of Immunology 17: 1367–1370, 1987.
   PubMed Web of Science ®Google Scholar
• Cook L, Midgett J, Willis D, Clinton B, Folds JD: Evaluation of latex-based hetero-phile antibody assay for diagnosis of acute infectious mononucleosis. Journal of Clinical Microbiology 25 (12): 2391–2394, 1987.
   PubMed Web of Science ®Google Scholar
• Coombs RRA, Gurner BW, Wilson AB, Holm G, Lindgren B: Rosette-formation be-tween human lymphocytes and sheep red cells not involving immunoglobulin re-ceptors. International Archives of Allergy 39: 658–663, 1970.
   PubMedGoogle Scholar
• Cuende JI, Civeira P, Diez N, Prieto J: High prevalence without reactivation of herpesvirus 6 in subjects with chronic fatigue syndrome. Armies de Medicina Interna 14 (9): 441–444, 1997.
   Google Scholar
• Dahr W, Uhlenbruc G: Structural properties of the human MN blood group antigen re-ceptor sites. Journal of Physiological Chemistry 259: 835–843, 1978.
   Google Scholar
• Davidsohn I: Serologic diagnosis of infectious mononucleosis. Journal of the Ameri-can Medical Association 108: 289–295, 1937.
   Google Scholar
• Davidsohn I, Walker PH: The nature of the heterophilic antibodies in infectious mono-nucleosis. American Journal of Clinical Pathology 5: 455–465, 1935.
   Google Scholar
• De Ory F, Echevaria TM: Evaluation of serological criteria for the diagnosis of infec-tious mononucleosis. Enfermedades Infecciosas y Microbiologia Clinica 7 (9): 485–498, 1989.
   PubMedGoogle Scholar
• De Vinci C, Levine PH, Pizza G, Fudenberg HH, Orens P, Pearson G, Viza D: Lessons from a pilot study of transfer factor for the treatment in chronic fatigue syndrome. Biotherapy 9 (1-3): 87–90, 1996.
   PubMedGoogle Scholar
• Dillner J, KaIlin B: The Epstein-Barr virus proteins. Advances in Cancer Research 50:95–158, 1988.
   PubMed Web of Science ®Google Scholar
• Duk M, Lisowska E, Kordowicz M, Wasniowska K: Studies on the specificity of the binding site of Vicia graminea anti-N lectin. European Journal of Biochemistry 123: 105–112, 1982.
   PubMedGoogle Scholar
• Duverlie G, Driencourt M, Rouse11 C, Orfila J: Heterophile IgM, IgA, and IgE antibod-ies in infectious mononucleosis. Journal of Medical Virology 28 (1): 38–41, 1989.
   Google Scholar
• Ebert W, Metz J, Roelcke D: Modifications of N-acetylneuraminic acid and their influ-ence on the antigen activity of erythrocyte glycoproteins. European Journal of Bio-chemistry 27: 470–472, 1972.
   Web of Science ®Google Scholar
• Ellman L, Carvalho A, Jacobson BM, et al.: Platelet autoantibody in a case of infec-tious mononucleosis presenting as thrombocytopenia purpura. American Journal of Medicine 55: 723–726, 1973.
   PubMed Web of Science ®Google Scholar
• Englund JA: The many faces of Epstein-Barr virus. Postgraduate Medicine 83 (2): 167–170, 1988.
   PubMed Web of Science ®Google Scholar
• Epstein MA, Aching BG, Barr Y: Virus particles in cultured lymphoblasts from Bur-kitt' s lymphoma. Lancet 1: 702–703, 1964.
   PubMed Web of Science ®Google Scholar
• Ernberg I, Andersson J, Linde A: Epstein-Barr virus infection—clinical aspects and di-agnosis. Nordisk Medicin. 105 (1): 19–23, 1990.
   Google Scholar
• Evans AS, Niederman JC, Cenabre LC, West B, Richards VA: A prospective evalua-tion of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody. Journal of Infectious Diseases 132: 546–554, 1975.
   PubMed Web of Science ®Google Scholar
• Evans AS, Niederman JC: EBV-IgA and new heterophile antibody tests in diagnosis of infectious mononucleosis. American Journal of Clinical Pathology 77: 555–560, 1982.
   PubMed Web of Science ®Google Scholar
• Farber Y, Wutzler P, Wohlrabe P, Wolf H, Hinderer W, Sonneborn HH: Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombi-nant ELISAs. Journal of Virological Methods 42 (2-3): 301–307, 1994.
   Web of Science ®Google Scholar
• Farhat SE, Finn S, Chua R, Smith B, Simor AE, George P, Diena BB, Skulnick M: Rapid detection of infectious mononucleosis-associated heterophile antibodies by a novel immunochromatographic assay and a latex agglutination test. Journal of Clin-ical Microbiology 31(6): 1597–1600, 1993.
   PubMed Web of Science ®Google Scholar
• Fleischer G, Henle W, Henle G, Lennette ET, Biggar RJ: Primary Epstein-Barr virus infection in American infants: clinical and serological observations. Journal of In-fectious Diseases 139: 553–558, 1979.
   PubMedGoogle Scholar
• Fletcher MA, Woolfolk BJ: Immunochemical studies of infectious mononucleosis. II. Sodium dodecyl sulfate gel electrophoresis of membrane glycoprotein antigens. Biochimica et Biophysica Acta 278: 163–174, 1971.
   Google Scholar
• Fletcher MA, Lo TM: Immunochemical studies of infectious mononucleosis. III. Iso-lation and characterization of heterophile antibodies. Clinical and Experimental Im-munology 16: 607–614, 1974.
   Google Scholar
• Fletcher MA, Caldwell KE, Latif ZA, Cayer M, Caflin A: Immunochemical studies of infectious mononucleosis. VIII. A glycoprotein from sheep erythrocytes with sialic acid-dependent receptor properties. Journal of Immunology 128: 976–982, 1982a.
   Google Scholar
• Fletcher MA, Caldwell KE, Latif Z: Immunochemical studies of infectious mononu-cleosis. IX. Heterophile antigen associated with a glycoprotein from the bovine erythrocyte membrane. Vox Sanguini 43: 53–70, 1982b.
   Google Scholar
• Frizzera G: The clinico-pathological expressions of Epstein-Barr virus infection in lymphoid tissues. Virchows Archiv. B. 53: 1–12, 1987.
   Google Scholar
• Fukuda K, Tomita M, Hamada A: Isolation and characterization of alkali-labile oligosaccharide units from horse glycophorin. Journal of Biochemistry 87: 687–693, 1980.
   PubMed Web of Science ®Google Scholar
• Gasa S, Makita A, Kinoshita Y: Further study of the chemical structure of the equine erythrocyte hemnatoside containing 0-acetyl ester. Journal of Biological Chemis-try 258: 876–881, 1983.
   PubMed Web of Science ®Google Scholar
• Glaser R, Kiecolt-Glaser JK: Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. American Journal of Medicine 105 (3A): 35S-42S, 1998.
   Google Scholar
• Glaudetuans CPJ: Immunodominance of terminal sugars revisited. Molecular Immu-nology 23: 917–918, 1986.
   PubMed Web of Science ®Google Scholar
• Gleeson-White MH, Head DH, Mynors LS, Coombs RRA: Factors influencing the agglutinability of red cells: the demonstration of a variation in the susceptibility to agglutination exhibited by the red cells of individual oxen. British Journal of Exper-imental Pathology 31: 321–331, 1950.
   PubMed Web of Science ®Google Scholar
• Gorgievski-Hsiroho M, Hinderer W, Nebel-Schickel H, Horn J, Vomhagen R, Sonneborn HH, Wolf H, Siegl G: Serodiagnosis of infectious mononucleosis by using recom-binant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay tech-nology. Journal of Clinical Microbiology 28 (10): 2305–2311, 1990.
   PubMed Web of Science ®Google Scholar
• Gray JJ, Caldwell J, Sillis M: The rapid serological diagnosis of infectious mononucle-osis. Journal of Infection 25 (1): 9–46, 1992.
   Google Scholar
• Green JA, Dawson AA, Valerio D: Hodgkin's disease and infectious mononucleosis. Scandinavian Journal of Haematology 23: 313–314, 1979.
   PubMedGoogle Scholar
• Grose C: The many faces of infectious mononucleosis: the spectrum of Epstein-Barr virus infection in children. Pediatrics in Review 7 (2): 35–44, 1995.
   Google Scholar
• Hakomori S, Wang S-M, Young WW, Jr: Isoantigenic expression of Forssman glyco-lipid in human gastric and colonic mucosa: its possible identity with "A-like anti-gen" on human cancer. Proceedings of the National Academy of Sciences of the United States of America 74: 3023–3027, 1977.
   PubMed Web of Science ®Google Scholar
• Halprin J, Scott AL, Jacobsen L, Levine PH, Ho JHC, Niederman JC, Hayward SD, Milman 0: Enzyme-linked immunosorbent assay of antibodies to Epstein-Barr vi-rus nuclear and early antigen in patients with infectious mononucleosis and naso-pharyngeal carcinoma. Annals of Internal Medicine 104: 331–337, 1986.
   PubMed Web of Science ®Google Scholar
• Hamilton PJ, Edmond E, Davidson RJL: False-positive infectious mononucleosis se-rology in epilepsy. Journal of Clinical Pathology 28: 807–811, 1975.
   PubMed Web of Science ®Google Scholar
• Hana I, Vrubel J, Pekarek J, Cech K: The influence of age on transfer factor treatment of cellular immunodeficiency, chronic fatigue syndrome and/or chronic viral infec-tions. Biotherapy 9 (1-3): 91–95, 1996.
   PubMedGoogle Scholar
• Hardy RE, Batstone-Cunningham RL, Dill K: Possible 1-3C reductive methylation of glycophorin A. Possible relation of the N-terminal amino acid and the lysine resi-dues to MN blood group specificities. Archives of Biochemistry and Biophysics 222: 222–230, 1983.
   Google Scholar
• Harrington DS, Weisenburger DD, Purtilo DT: Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer 59 (8): 1419–1429, 1987.
   PubMed Web of Science ®Google Scholar
• Harrington DS, Weisenburger DD, Purtilo DT: Epstein-Barr virus-associated lympho-proliferative lesions. Clinical Laboratory Medicine 8 (1): 97–118, 1988.
   PubMed Web of Science ®Google Scholar
• Haukenes G, Viggen B, Boye B, Kalvenes MB, Flo R, Kalland KH: Viral antibodies in infectious mononucleosis. FEMS Immunology and Medical Microbiology 8 (3): 219–224, 1994.
   PubMed Web of Science ®Google Scholar
• Hendry BM, Longmore TM: Systemic lupus erythematosus presenting as infectious mononucleosis with a false-positive Monospot test. Lancet 1: 455, 1982.
   PubMed Web of Science ®Google Scholar
• Henle G, Henle W: Immunofluorescence in cells derived from Burkitt's lymphoma. Journal of Bacteriology 91: 1248–1256, 1966.
   PubMed Web of Science ®Google Scholar
• Henle W, Henle G, Andersson J, Ernberg J, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder JC, Straus SE: Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus in-fection. Proceedings of the National Academy of Sciences of the United States of America 84: 570–574, 1987.
   PubMed Web of Science ®Google Scholar
• Higashi H, Hirabayashi Y, Fukui Y, Naiki M, Marsumoto M, Ueda S, Kato S: Charac-terization of N-glycolylneuraminic acid-containing gangliosides as tumor-associ-ated Hanganutzui-Deicher antigen in human colon cancer. Cancer Research 45: 3796–3802, 1985.
   PubMed Web of Science ®Google Scholar
• Ho DWT, Field PR, Cunningham AT: Rapid diagnosis of acute Epstein-Barr virus in-fection by an indirect enzyme-linked immunosorbent assay for specific immuno-globulin M (IgM) antibody without rheumatoid factor and specific IgG interference. Journal of Clinical Microbiology 27: 952–958, 1989.
   PubMed Web of Science ®Google Scholar
• Hoiby EA, Tjade T, Rotterud OL: Evaluation of ten commercial heterophile antibody tests for infectious mononucleosis. Acta Path. Microbiol. Immunol. Scand. 93: 145–151, 1985.
   Google Scholar
• Horwitz CA, Moulds J, Henle W, Henle G, Polesky H, Balfour HH, Jr, Schwartz B, Hoff T: Cold agglutinins in infectious mononucleosis and heterophile-antibody-negative mononucleosis-like syndrome. Blood 50: 195–202, 1977.
   PubMed Web of Science ®Google Scholar
• Horwitz CA, Polesky H, Stillman T, Ward PCJ, Henle G, Henle W: Persistent hemagglutination for infectious mononucleosis in rheumatoid arthritis. British Medical Journal 1: 591–592, 1973.
   PubMed Web of Science ®Google Scholar
• Horwitz CA, Henle W, Henle G, Penn G, Hoffman N, Ward PCJ: Persistent falsely positive rapid test for infectious mononucleosis. American Journal of Clinical Pa-thology 72: 807–811, 1979.
   PubMed Web of Science ®Google Scholar
• Hossain A: Infectious mononucleosis and mononucleosis-like illnesses in children and adults in Saudi Arabia. Journal of Tropical Pediatrics 35 (3): 121–125, 1989.
   PubMed Web of Science ®Google Scholar
• Hunig T: The cell surface molecule recognized by the erythrocyte receptor of T lym-phocytes. Identification and partial characterization using a monoclonal antibody. Journal of Experimental Medicine 162: 890–901, 1985.
   Google Scholar
• Hunig T, Mitnacht R, Tiefenthaler G, Kohler C, Miyasaka: T11TS, the cell surface molecule binding to the "erythrocyte receptor" of T lymphocytes: cellular distribu-tion, purification to homogeneity and biochemical properties. European Journal of Immunology 16: 1615–1621, 1986.
   Google Scholar
• Hunig T, Tiefenthaler G, Meyer zum Buschenfelde K-H, Meuer SC: Alternative path-way activation of T cells by binding CD2 on its cell-surface ligand. Nature 326: 298–301, 1987.
   PubMed Web of Science ®Google Scholar
• Iijima H, Ogawa T: Total synthesis of 3-042-aceteamido-6-0-N-acetyl-a-D-galactosyll-L-serine and a stereoisomer. Carbohydrate Research 172: 183–193, 1988.
   PubMedGoogle Scholar
• Jagielski M, Kaluzewski S: Heterophilic infectious mononucleosis antigen used in the latex diagnostic test. II. Preliminary evaluation of the usefulness of latex reagents for detection of serum heterophile antibodies in patients with infectious mononu-cleosis. Medycyna Doswiadczalna I Mikrobiologia 42 (1–2): 77–83, 1990.
   Google Scholar
• Jondal M, Holm G, Wigzell H: Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. Journal of Experimental Medicine 136: 207–215, 1972.
   Google Scholar
• Jones JF, Straus SE: Chronic Epstein-Barr virus infection. Annual Reviews of Medi-cine 38: 195–209, 1987.
   PubMed Web of Science ®Google Scholar
• Judd WJ, Is sit PD, Pavone G, Anderson J, Aminoff D: Antibodies that define NANA-independent MN-system antigens. Transfusion 19: 12–18, 1979.
   PubMed Web of Science ®Google Scholar
• Kaluzewski S, Jagielski M: Heterophile infectious mononucleosis antigen used in the latex diagnostic test. I. A method of antigen isolation and its serologic activity. Medycyna Doswiadczalna I Mikrobiologia 42 (1–2): 68–76, 1990.
   Google Scholar
• Kano K, Milgrom F: Heterophile antigens and antibodies in medicine. Current Topics in Microbiology and Immunology 77: 43–69, 1977.
   PubMedGoogle Scholar
• Kano K, Milgrom F: Studies on the Paul-Bunnell (P-B) antigen-antibody system. IV. Unresponsiveness to one of the P-B antigens in infectious mononucleosis. Clinical Immunology and Immunopathology 27: 293–299, 1983.
   Google Scholar
• Kano K, Merrick JM, Milgrom F: Classification of human heterophile antibodies. International Archives of Allergy and Applied Immunology 73: 373–377, 1984a. Kano K, Tamura T, Milgrom F: Paul-Bunnell antigen in normal human tissues. Diagnostic Immunology 2: 105–108, 1984b.
   Google Scholar
• Kataaha PK, Mortazavi-Milani SM, Russell G, Holborow EJ: Anti-intermediate fila-ment antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid ar-thritis and infectious mononucleosis. Annals of Rheumatologic Diseases 44: 446–449, 1985.
   PubMed Web of Science ®Google Scholar
• Killeen N, Moessner R, Arvieux J, Willis A, Williams AF: The MRC OX-45 antigen of rat leukocytes and endothelium is in a subset of the immunoglobulin superfamily with CD2, LFA-3 and carcinoembryonic antigens. EMBO Journal 7: 3087–3091, 1988.
   PubMed Web of Science ®Google Scholar
• Kim M, Wadke M: Comparative evaluation of two test methods (enzyme immuno-assay and latex fixation) for the detection of heterophil antibodies in infectious mononucleosis. Journal of Clinical Microbiology 28: 2511–2513, 1990.
   PubMed Web of Science ®Google Scholar
• Kitao T, Takeshita M, Hattori K: Studies on glycopeptide released by trypsin from sheep erythrocytes. Journal of Immunology 117: 310–312, 1976.
   PubMed Web of Science ®Google Scholar
• Klenmola E, von Essen R, Henle G, Henle W: Infectious mononucleosis-like disease with negative heterophile agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibody. Journal of Infectious Diseases 121: 608–614, 1970.
   Google Scholar
• Klimas NG, Caldwell KE, Whitney PL, Fletcher MA: Comparison of receptor proper-ties of erythrocyte membrane glycoproteins. Developmental and Comparative Im-munology 6: 765–774, 1982.
   PubMed Web of Science ®Google Scholar
• Kopel S, Taub RN, Madyastha KR, Deutsch V, Baker MA: Monosaccharide inhibition of E-rosette formation. Clinical Immunology and Immunopathology 15: 651–657, 1980.
   PubMedGoogle Scholar
• Lalezari P, Nehlsen SL, Novodoff J, Lalezari I: Role of amino groups in formation of human lymphocyte-xenogeneic erythrocyte rosettes; a proposed mechanism for an-tigen recognition. Proceedings of the National Academy of Sciences of the United States of America 72: 697–700, 1975.
   PubMed Web of Science ®Google Scholar
• Lalor BC, Feely J, Drury MI: A positive Monospot in a diabetic with sarcoidosis. Irish Journal of Medical Sciences 145: 58–59, 1976.
   PubMed Web of Science ®Google Scholar
• Langhorne J, Feizi T: Studies on the heterophile antibodies of infectious mononucleo-sis. I. Separation of four antibody populations, one of which contains lympho-cytotoxic activity. Clinical and Experimental Immunology 30: 354–363, 1977.
   Google Scholar
• Lay WH, Mendes NF, Bianco C, Nussenzweig V: Binding of sheep red blood cells to a large population of human lymphocytes. Nature 230: 531–532, 1971.
   PubMed Web of Science ®Google Scholar
• Lee CL, Takahashi T, Davidsohn I: Sheep erythrocyte agglutinins and beef erythrocyte hemolysins in infectious mononucleosis serum. Journal of Immunology 91: 783–790, 1963.
   PubMed Web of Science ®Google Scholar
• Lee CL, Zandrew F, Davidsohn I: Horse agglutinins in infectious mononucleosis. III. Criterion for differential diagnosis. Journal of Clinical Pathology 21: 631–634, 1968a.
   PubMed Web of Science ®Google Scholar
• Lee CL, Davidsohn I, Slaby R: Horse agglutinins in infectious mononucleosis. Ameri-can Journal of Clinical Pathology 49: 3–11, 1968b.
   PubMed Web of Science ®Google Scholar
• Lemon SM, Hutt LM, Shaw JE, Li HI, Pagano JS: Replication of EBV in epithelial cells during infectious mononucleosis. Nature 268: 268–270, 1977.
   PubMed Web of Science ®Google Scholar
• Lennette ET, Henle W: Epstein-Barr virus infections: clinical and serologic features. Lab. Manage. 25: 23–28, 1987.
   Google Scholar
• Levine D, Tilton RC, Parry MF, Klenk R, Morelli A, Hofreuter N: False-postive EBNA IgM and IgG antibody tests for infectious mononucleosis in children. Pedi-atrics 94 (6 Pt 1): 892–894, 1994.
   Google Scholar
• Levine P, Gilmore EL: The first stage of antigen-antibody reaction in infectious mono-nucleosis. Science 101:411–412, 1945.
   PubMed Web of Science ®Google Scholar
• Levine PH: The use of transfer factors in chronic fatigue syndrome: Prospects and problems. Biotherapy 9 (1-3): 77–79, 1996.
   PubMedGoogle Scholar
• Liao T-H, Gallop PM, Blumenfeld 00: Modification of sialyl residues of sialo-glycoprotein(s) of the human erythrocyte surface. Journal of Biological Chemistry 248: 8247–8253, 1973.
   PubMed Web of Science ®Google Scholar
• Linderholm M, Boman J, tufo P, Linde A: Comparative evaluation of nine kits for rapid diagnosis of infectious mononucleosis and Epstein-Barr virus-specific serol-ogy. Journal of Clinical Microbiology 32 (1): 259–261, 1994.
   PubMed Web of Science ®Google Scholar
• Lisowska E, Moraiwecki: The role of free amino groups in the blood group activity of M and N mucoids. European Journal of Biochemistry 3 (2): 237–241, 1967.
   PubMedGoogle Scholar
• Lisowska E, Duk M: Modification of amino groups of human erythrocyte glyco-proteins and the new concept on the structural basis of M and N blood-group speci-ficity. European Journal of Biochemistry 54: 469–474, 1975a.
   PubMedGoogle Scholar
• Lisowska E, Duk M: Effects of modification of amino groups of human erythrocytes on M, N, and Nvg blood group specificities. Vox Sanguini 28: 392–397, 1975b. Lisowska E, Kordowicz M: Specific antibodies for desialized M and N blood groups antigens. Vox Sanguini 33: 164–169, 1977.
   Google Scholar
• Lisowska E, Wasnioska K: Immunochemical characterization of cyanogens bromide degradation products of M and N blood group glycopeptides. European Journal of Biochemistry 88: 247–252, 1978.
   PubMedGoogle Scholar
• Lowenthal RM, McLauchlan SL, Tyre11 DA: Human antigen for the Paul-Bunnell anti-body. Nature 244: 109–111, 1973.
   Web of Science ®Google Scholar
• Mangi RJ, Niederman JC, Keletter JE, Jr, Dwyer JM, Elans AS, Kantor FS: Depression of cell-mediated immunity during acute infectious mononucleosis. New England Journal of Medicine 291: 1149–1155, 1974.
   PubMed Web of Science ®Google Scholar
• Markowitz A, Simmonds WL: Chemical and immunologic studies on a heterophile fraction isolated from bovine erythrocyte stroma. I. Chemical studies. Journal of Immunology 7145–7151, 1953.
   Google Scholar
• Marsh S, Kaplan M, Asano Y, Hoekzema D, Komaroff AL, Whitman JE, Jr, Ablashi DV: Development and application of HHV-6 antigen capture assay for the detec-tion of HHV-6 infections. Journal of Virological Methods 61(1–2): 103–112, 1996.
   Google Scholar
• Martin PJ, Longton G, Ledbetter JA, Newman M, Braun P, Beatty PG, Hansen JA: Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50. Journal of Immunology 131: 180–185, 1983.
   PubMed Web of Science ®Google Scholar
• Martin WJ: Detection of RNA sequences in cultures of stealth virus isolated from the cerebrospinal fluid of a health care worker with chronic fatigue syndrome. Case re-port. Pathobiology 64 (1): 1–8, 1996a.
   PubMedGoogle Scholar
• Martin WJ: Genetic instability and fragmentation of a stealth viral genome. Patho-biology 64 (1): 9–17, 1996b.
   Google Scholar
• Martin WJ: Cellular sequences in stealth viruses. Pathobiology 66 (2): 53–58, 1998.
   PubMed Web of Science ®Google Scholar
• Martinez Zapico R, Sobejano L, Llamazares I, Ladron de Guevara C: Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA. Enfermedades Infecciosas y Microbiologia Clinica 10(5): 281–283, 1992.
   Google Scholar
• Masaki M, Kano M, Merrick TM, Milgrom F: Studies on Paul-Bunnell (P-B) anti-gen-antibody system. I. Two distinct P-B antigens. International Archives of Al-lergy and Applied Immunology 65: 313–322, 1981a.
   PubMedGoogle Scholar
• Masaki M, Kano M, Merrick TM, Milgrom F: Studies on Paul-Bunnell (P-B) anti-gen-antibody system. II. P-B antigens in extracts of lymphoma-leukemia spleens and pathologic sera. Journal of Immunology 127: 5–8, 1981b.
   Google Scholar
• McKenzie H, Parrratt D, White RG: IgM and IgG antibody levels to ampicillin in pa-tients with infectious mononucleosis. Clinical and experimental Immunology 26: 214–221, 1976.
   PubMed Web of Science ®Google Scholar
• Merrick TM, Schifferele R, Sadarlik K, Kano K, Milgrom F: Isolation and partial char-acterization of the heterophile antigen of infectious mononucleosis from bovine erythrocytes. Journal of Supramolecular Structure 6: 275–290, 1977.
   PubMedGoogle Scholar
• Merrill RH, O'Neill B: Positive Monospot test in histiocytic medullary reticulosis. American Journal of Clinical Pathology 65: 407–411, 1976.
   PubMed Web of Science ®Google Scholar
• Meuer SC, Hussey RE, Fabbi M, Fox D, Acuto O, Fitzgerald KA, Hodgdon JC, Protentis JP, Schlossman SF, Reinherz EL: An alternative pathway of T cell activa-tion: a functional role for the 50 kDa T11 sheep erythrocyte receptor protein. Cell 36: 897–906, 1984.
   PubMed Web of Science ®Google Scholar
• Meuer SC, Roux MM, Schraven B: The alternative pathway of T cell activation: biol-ogy, pathophysiology, and perspectives for immunopharmacology. Clinical Immu-nology and Immunopathology 50: S133–S139, 1989.
   PubMed Web of Science ®Google Scholar
• Miale TD, Barbosa IL, Dellinger CT, Wolfson SL: Positive Monospot test preceding the diagnosis of acute monocytic leukemia in two adolescents. Medical Pediatric Oncology 4: 111–114, 1978.
   PubMedGoogle Scholar
• Milgrom F, Loza U: Agglutination of particulate antigens in agar gel. Journal of Immu-nology 98: 102–109, 1967.
   PubMed Web of Science ®Google Scholar
• Milgrom F, Kano K, Fjelde A: Studies on heterophile antigen in lymphoma and leuke-mia spleens by means of absorption of infectious mononucleosis sera. International Archives of Allergy 45: 631–637, 1973.
   PubMedGoogle Scholar
• Milgrom F, Kano K, Fjelde A, Bloom ML: Heterophile antigens and antibodies in transplantation and tumors. Transplant Proceedings 7 (2): 201–207, 1975.
   PubMed Web of Science ®Google Scholar
• Moingeon P, Chang HC, Sayres PH, Claytoon LK, Alcover A, Gardner P, Reinherz EL: The structural biology of CD2. Immunological Reviews 111: 111–144, 1989.
   PubMed Web of Science ®Google Scholar
• Mookerjee BK, Jung CY: Effects of cytochalasins on lymphocytes: mechanism of in-hibition of rosette formation. Journal of Immunology 131: 1126–1130, 1983.
   PubMed Web of Science ®Google Scholar
• Morito T, Kano K, Milgrom F: Studies on the Paul-Bunnell antigen-antibody system. III. Detection of a Paul-Bunnell-related antigen in syphilis and leprosy. Interna-tional Archives of Allergy and Applied Immunology 71: 117–121, 1983.
   Google Scholar
• Mueller N: Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodg-kin's disease. Yale Journal of Biological Medicine 60 (4): 321–332, 1987.
   PubMed Web of Science ®Google Scholar
• Mukuria CJ, Naili M, Kato S: Microstructure of the sialic acid moiety of N-glyco-lylneuraminyllactosyl-ceramide and the elucidation of Hanganutziu and Deicher (HD) antigenicity. Immunology Letters 12: 165–169, 1986a.
   PubMed Web of Science ®Google Scholar
• Mukuria CJ, Fujii Y, Kato S, Naili M: Specificities of human heterophile Hanganutziu and Deicher (HD) antibodies to glycosphingolipids and a glycoprotein. Journal of Biochemistry 100: 469–475, 1986b.
   PubMed Web of Science ®Google Scholar
• Murayama J-I, Tomita M, Hamada A: Primary structure of horse erythrocyte glyco-phorin HA. Its amino acid sequence has a unique homology with those of human and porcine erythrocyte glycophorins. Journal of Membrane Biology 64: 205–215, 1992.
   Google Scholar
• Myrmel H: Comparison of tests for heterophile antibodies with a test for specific IgM-antibodies to Epstein-Barr virus. Brief report. APMIS 96 (3): 280–281, 1988.
   PubMed Web of Science ®Google Scholar
• Niedobitek G, Hamilton-Dutoit S, Herbst H, Finn T, Vetner M, Pallesen G, Stein H: Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization. Human Pathology 20: 796–799, 1989.
   PubMed Web of Science ®Google Scholar
• Niller HH, Wolf H: Epstein-Barr virus. Zentralblatt fur Hygiene und Umweltmedizin 194 (1-2): 118–125, 1993.
   PubMedGoogle Scholar
• Nishimaki L, Kano K, Milgrom F: Paul-Bunnell antigen in malignancies and rheuma-toid arthritis. International Archives of Allergy and Applied Immunology 60: 115–119, 1979.
   PubMedGoogle Scholar
• Nowak JA, Jain NK, Stinson MW, Merrick TM: Interaction of bovine erythrocyte N-glycolylneuraminic acid-containing gangliosides and glycoproteins with a hu-man Hanganutziu-Deicher serum. Molecular Immunology 23: 693–700, 1986.
   PubMed Web of Science ®Google Scholar
• Numata M, Sugimoto M, Shibayama S, Ogawa T: A total synthesis of hematoside, a-NeuGc-(2-3)-13-Gal-(1-4)-13-Glc-(1-1)-Cer. Carbohydrate Research 174: 73–83, 1988.
   PubMed Web of Science ®Google Scholar
• Oh S-K, Farrar W, Ruscetti FVV: Modulation of E-receptor expression on activated T lymphocytes. Clinical Immunology and Immunopathology 38: 55–67, 1986.
   PubMedGoogle Scholar
• Okano M, Thiele GM, Davis JR, Grierson HL, Purtilo DT: Epstein-Barr virus and hu-man diseases: recent advances in diagnosis. Clinical Microbiology Reviews 1 (3): 300–312, 1988.
   PubMedGoogle Scholar
• Papaevagelou G, Roumelioutou A, Alexiou D, Politou E, Papadatos C: Diagnostic value of IgG and IgM antibodies to capsid antigen of Epstein-Barr virus in infec-tious mononucleosis. Journal of Infectious Diseases 136: 428–431, 1977.
   PubMed Web of Science ®Google Scholar
• Paul JR, Bunnell WW: The presence of heterophile antibodies in infectious mononu-cleosis. American Journal of Medicine 183: 91–104, 1932.
   Google Scholar
• Phillips GM: False-positive Monospot result in rubella. Journal of the American Medi-cal Association 222: 585, 1972.
   PubMed Web of Science ®Google Scholar
• Pearson GR, Neel III HB, Weiland LH, Mulroney SE, Taylor W, Goepfert H, Huang A, Levine P, Lanier A, Pilch B: Antibody dependent cellular cytotoxicity and dis-ease course in North American patients with nasopharyngeal carcinoma: a prospec-tive study. International Journal of Cancer 33: 777–782, 1984.
   PubMed Web of Science ®Google Scholar
• Pike RM, Schulze ML: Agglutination in rheumatoid arthritis serum of sheep cells sen-sitized with hemolysin and infectious mononucleosis agglutinins. Journal of Immu-nology 85: 523–529, 1960.
   PubMed Web of Science ®Google Scholar
• Plunkett ML, Springer TA: Purification and characterization of the lymphocyte func-tion-associated-2 (LFA-2) molecule. Journal of Immunology 136: 4181–4187, 1986.
   PubMed Web of Science ®Google Scholar
• Pochedly C: Laboratory testing for infectious mononucleosis. Cautions to observe in interpreting results. Journal of Postgraduate Medicine 81(1): 335–339, 1987.
   Web of Science ®Google Scholar
• Poppema S, van Imhoff G, Torensma R, Smit J: Lymphadenopathy morphologically consistent with Hodgkin's disease associated with Epstein-Barr virus infection. American Journal of Clinical Pathology 84 (3): 385–390, 1995.
   Google Scholar
• Pounder RE, Chalmers DG: Observation on the ox cell haemolysins in human serum. Clinical and Experimental Immunology 2: 285–293, 1967.
   PubMedGoogle Scholar
• Prohaska R, Koerner TAW, Jr, Armitage IIV1, Furthmayr H: Chemical and carbon-13 nuclear magnetic resonance studies of the blood group M and N active sialo-glycopeptides from human glycophorin A. Journal of Biological Chemistry 256: 5781–5791, 1967.
   Google Scholar
• Pugh SF: Heterotypic reactions in radioimmunoassay for Coxsackie B virus specific IgM. Journal of Clinical Pathology 37: 433–439, 1984.
   PubMed Web of Science ®Google Scholar
• Purtilo DT: Epstein-Barr virus: the spectrum of its manifestations in human beings. Southern Medical Journal 80 (8): 943–947, 1987.
   PubMed Web of Science ®Google Scholar
• Purtilo DT, Sakamoto K, Saemundsen AK, Sullivan IL, Synnerholm A-C, Anvret M, Pritchard J, Sloper C, Sieff C, Pincott J, Pachhman L, Rich K, Cruzi F, Cornet JA, Collins R, Barnes N, Knight J, Sandstedt B, Klein G: Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lympho-proliferative diseases by clinical, virological, and immunopathological studies. Cancer Research 41: 4226–4236, 1991.
   Google Scholar
• Redelman D: Simultaneous increased expression of E-rosette receptor (CD2, T11) and t cell growth factor receptor on human T lymphocytes during activation. Cytometry 9: 156–163, 1988.
   PubMedGoogle Scholar
• Reed RE: False-positive Monospot tests in malaria. American Journal of Clinical Pa-thology 61: 173–175, 1974.
   PubMed Web of Science ®Google Scholar
• Rhodes G, Rumpold H, Kurki P, Pattrick KM, Carson DA, Vaughan JH: Auto-antibodies in infectious mononucleosis have specificity for the glycine-alanine re-peating region of the Epstein-Barr virus nuclear antigen. Journal of Experimental Medicine 165: 1026–1040, 1987.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Enders GH, Lifton RP: False-positive mononucleosis screening test results associated with Klebsiella hepatic abscess. American Journal of Clinical Pathology 94: 222–223, 1990.
   PubMed Web of Science ®Google Scholar
• Rocchi G, De Felici A, Ragona G, Heiz A: Quantitative evaluation of Epstein-Barr vi-rus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. New England Journal of Medicine 296: 132–134, 1977.
   PubMed Web of Science ®Google Scholar
• Rowe M, Cooney CM, Edwards CF, Lenovi GM, Rickinson AB: Epstein-Barr virus status and tumor cell phenotype in sporadic Burkitt's lymphoma. International Journal of Cancer 37: 367–373, 1986.
   PubMed Web of Science ®Google Scholar
• Sadler JE, Paulson JC, Hill RL: The role of sialic acid in the expression of human MN blood group. Journal of Biological Chemistry 254: 2112–2119, 1979.
   PubMed Web of Science ®Google Scholar
• Saemundsen AK, Purtilo DT, Sakamoto K, Sullivan IL, Synnerholm AC, Hanto D, Simmons R, Anvret M, Collins R, Klein G: Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Research 41: 4237–4242, 1981.
   PubMed Web of Science ®Google Scholar
• Saez L, Latif Z, Caldwell K, Fletcher MA: Heterophile antigen common to human tis-sues and bovine erythrocytes, In: Non-HLA Antigens in Health, Aging and Malig-nancy (Cohen E, Singal DP, Eds.) Alan R. Liss Co., New York, 1983.
   Google Scholar
• Saloff L, Goldsmith 0: False-positive infectious mononucleosis spot test in pancreatic carcinoma. Journal of the American Medical Association 218: 1297–1298, 1971.
   Web of Science ®Google Scholar
• Sayre PH, Chang H-C, Hussey RE, Brown NR, Richardson NE, Spagnoli G, Clayton LK, Reinherz EL: Molecular cloning and expression of T11 cDNAs reveals a recep-tor-like structure on human T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 84: 2941–2945, 1987.
   PubMed Web of Science ®Google Scholar
• Schmaling KB, Jones JF: MMPI profiles of patients with chronic fatigue syndrome. Journal of Psychosomatic Research 40 (1): 67–74, 1996.
   PubMed Web of Science ®Google Scholar
• Schwarzweiss H, Tomcsik J: isolation of the heterogenic "mononucleosis antigen" from the stroma of beef erythrocytes. Society of Experimental Biology and Medi-cine 69: 558–561, 1948.
   PubMed Web of Science ®Google Scholar
• Seed B, Arufo A: Molecular cloning of the CD2 antigen, the T-cell erythrocyte recep-tor, by a rapid immunoselection procedure. Proceedings of the National Academy of Sciences of the United States of America 84: 3365–3369, 1987.
   PubMed Web of Science ®Google Scholar
• Seitanidis B: A comparison of the Monospot with the Paul-Bunnell test in infectious mononucleosis and other diseases. Journal of Clinical Pathology 22: 321–323, 1969.
   PubMed Web of Science ®Google Scholar
• Selvaraj P, Plunkett ML, Dustin M, Sanders ME, Shaw S, Springer TA: The T lympho-cyte glycoprotein CD2 binds the cell surface ligand LFA-3. Nature 326: 400–403, 1987.
   PubMed Web of Science ®Google Scholar
• Sewell WA, Brown MH, Dunne J, Owen M, Crumpton Mk Molecular cloning of the human T-lymphocyte surface CD2 (T11) antigen. Proceedings of the National Academy of Sciences of the United States of America 83: 8718–8722, 1986.
   PubMed Web of Science ®Google Scholar
• Sewell WA, Brown MH, Owen MJ, Fink PJ, Kozak CA, Crumpton Mk The murine homologue of the T lymphocyte CD2 antigen: molecular cloning, chromosome assign-ment and cell surface expression. European Journal of Immunology 17: 1015–1020, 1987.
   PubMed Web of Science ®Google Scholar
• Shearer WT, Ritz J, Feingold MJ, Guerra IC, Rosenblatt HM, Lewis DE, Pollack MS, Tarbor LH, Sumaya CV, Grumet FC: Epstein-Barr virus associated B-cell prolifer-ations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. New England Journal of Medi-cine 312: 1151–1159, 1985.
   PubMed Web of Science ®Google Scholar
• Siddiqui B, Hakomori S-I: A revised structure for the Forssman glycolipid hapten. Journal of Biological Chemistry 246: 5766–5769, 1971.
   PubMed Web of Science ®Google Scholar
• Snydman DR, Rudders RA, Doust P, Sullivan JL, Evans AS: Infectious mononucleosis in an adult progressing to fatal immunoblastic lymphoma. Annals of Internal Medi-cine 96: 737–742, 1982.
   PubMed Web of Science ®Google Scholar
• Springer GF, Rapaport Mk Specific release of heterogenetic "mononucleosis recep-tor" by influenza viruses, receptor-destroying enzyme and plant proteases. Pro-ceedings of the National Academy of Sciences of the United States of America 96: 103–107, 1957.
   Google Scholar
• Springer GF, Ansell NJ: Inactivation of human erythrocyte agglutinogens M and N by influenza viruses and receptor-destroying enzyme. Proceedings of the National Academy of Sciences of the United States of America 44: 182–189, 1958.
   PubMed Web of Science ®Google Scholar
• Springer GF, Schwick HG, Fletcher MA: The relationship of the influenza virus inhibi-tory activity of glycoproteins to their molecular size and sialic acid content. Pro-ceedings of the National Academy of Sciences of the United States of America 64: 634–641, 1969.
   PubMed Web of Science ®Google Scholar
• Springer GF, Yang HJ: Effect of periodate oxidation on specific activities and carbo-hydrate components of human blood group N- and M- specific glycoproteins and glycopeptides. Vox Sanguini 35: 255–264, 1978.
   PubMed Web of Science ®Google Scholar
• Steeper TA, Horwitz CA, Henle W, Henle G: Selected aspects of acute and chronic in-fectious mononucleosis and mononucleosis-like illnesses for the practicing aller-gist. Annals of Allergy 59 (4): 243–249, 1997.
   Google Scholar
• Stites DP, Leikola J: Infectious mononucleosis. Seminars in Hematology 3: 243–260, 1971.
   Google Scholar
• Strannegard 0, Lycke E: Studies on antigen-antibody systems with reference to mono-nucleosis infectiosa. Acta Pathologica Microbiologica Scandinavica 60: 409–419, 1964.
   PubMedGoogle Scholar
• Streuli RA, Chung J, Scanu AM, Yachnin S: Inhibition of human lymphocyte E-rosette formation by oxygenated sterols. Journal of Immunology 123: 2897–2902, 1979. Stuart CA: Heterophile antibodies in infectious mononucleosis. Proceedings of the Society for Experimental Biology and Medicine 32: 861–864, 1935.
   Google Scholar
• Stuart CA, Griffin AM, Wheeler KM, Battey S: A thermostable antigen in beef cells. Proceedings of the Society for Experimental Biology and Medicine 34: 212–215, 1936a.
   Google Scholar
• Stuart CA, Welch H, Cunningham J, Burgess AM: Infectious mononucleosis. Further studies. Archives of Internal Medicine 58: 512–522, 1936b.
   Google Scholar
• Sumaya CV, Ench Y: Epstein-Barr virus infectious mononucleosis in children. II. Heterophile antibody and viral-specific responses. Pediatrics 75: 1011–1019, 1985.
   Google Scholar
• Tamura T, Kano K, Milgrom F: Studies on Paul-Bunnell (PB) antigen-antibody sys-tem. V. Immunoglobulin classes of P-B antibodies. Diagnostic Immunology 2: 191–196, 1984.
   PubMedGoogle Scholar
• Taylor RN, Ehrhard H-B, Marcus S: Evaluation of tests for infectious mononucleosis through proficiency testing. Hospital Laboratory Sciences 13: 34–44, 1975. Thompson MP: The diagnosis of mononucleosis in the office laboratory. Primary Care Clinics in Office Practice 13 (4): 647–655, 1986.
   Google Scholar
• Tilton RC, Doas F, Ryan RW: Comparative evaluation of three commercial tests for detection of heterophile antibody in patients with infectious mononucleosis. Jour-nal of Clinical Microbiology 26 (2): 275–278, 1988.
   PubMed Web of Science ®Google Scholar
• Tomcsik J: The serological diagnosis of infectious mononucleosis. Triangle 5: 114–120, 1961.
   PubMedGoogle Scholar
• Tripathy BK, Agarwal AK, Sangla KS, Singh CP, Chandra S: Infectious agents and immunological disturbances in relation to chronic fatigue syndrome. Journal of the Association of Physicians of India 44 (5): 335–338, 1996.
   PubMedGoogle Scholar
• Uldall A, Jensen BS, Henrichsen J: Kits for the diagnosis of infectious mononucleosis compared with the Paul-Bunnell test. Journal of Clinical Chemistry and Clinical Biochemistry 28 (6): 423–425, 1990.
   PubMedGoogle Scholar
• Vahlne A, Jertborn M, Iwarson S: Mumps occurring as a mononucleosis-like syn-drome with positive Monospot test. Journal of the American Medical Association 242: 711, 1979.
   Web of Science ®Google Scholar
• Van Essen GG, Lieverse AG, Sprenger HG, Schirm J, Weits J: False-positive Paul-Bunnell test in HIV seroconversion. Lancet 2: 747–748, 1989.
   Web of Science ®Google Scholar
• Van Wauwe J, Goosens J, Decock W, Kung P, Goldstein G: Suppression of human T-cell mitogenesis and E-rosette formation by the monoclonal antibody OKT1 la. Immunology 44: 865–871, 1981.
   PubMed Web of Science ®Google Scholar
• Van Wauwe J, Goosens J: E-rosette formation at 37oC: analysis with monoclonal OKT antibodies. Cellular Immunology 68: 181–186, 1982.
   PubMed Web of Science ®Google Scholar
• Venables PJVV, Pawlowski T, Mumford PA, Brown C, Crawford DH, Maini RN: Re-action of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen 1. Annals of Rheumatic Dis-eases 47: 270–279, 1988.
   PubMed Web of Science ®Google Scholar
• Volpi RG: Natural history, diagnosis, and management of Epstein-Barr virus infec-tions. Alabama Journal of Medical Sciences 22: 157–159, 1985.
   PubMedGoogle Scholar
• Votava M: A new modification of the horse erythrocyte agglutination test for the detec-tion of heterophilic antibodies in infectious mononucleosis. Ceskoslovenska Epi-demiologie, Mikrobiologie, Immunologie 41(6): 317–326, 1992.
   PubMedGoogle Scholar
• Wanwright TW, Vectri RW, Sprinkle PM: Abrogation of cell-mediated immunity by a serum blocking factor isolated from patients with infectious mononucleosis. Jour-nal of Infectious Diseases 140: 22–32, 1979.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Hakomori S, Powell ME, Yokota M: The amphipathic membrane pro-teins associated with gangliosides: the Paul-Bunnell antigen is one of the ganglio-philic proteins. Biochemical and Biophysical Research Communications 92: 638–659, 1989.
   Google Scholar
• Weiss LM, Movahed LA: In situ demonstration of Epstein-Barr viral genomes in vi-ral-associated B cell lymphoproliferations. American Journal of Pathology 134: 651–659, 1989.
   PubMed Web of Science ®Google Scholar
• Weiss LM, Mohaved LA, Warnke RA, Sklar J: Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. New England Journal of Medicine 320 (8): 502–506, 1989.
   PubMed Web of Science ®Google Scholar
• White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Hangro HO, Clare AW: Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiat-ric disorders after glandular fever. British Journal of Psychiatry 173: 475–481, 1998.
   PubMed Web of Science ®Google Scholar
• Wilkinson PC, Carmichael DS: Immunochemical characterization and serological be-havior of antibodies against red cells in infectious mononucleosis. Journal of Labo-ratory Clinical Medicine 64: 529–539, 1964.
   PubMed Web of Science ®Google Scholar
• Wilmes E, Wolf H: Epstein-Barr virus infections. New pathogenic and clinical aspects. Laryngologie, Rhinologie, Otologie 68 (1): 36–43, 1970.
   Google Scholar
• Wolf P, Dorfman R, McClenahan J, Collins F: False-positive infectious mononucleo-sis spot test in lymphoma. Cancer 25: 626–628, 1970.
   PubMed Web of Science ®Google Scholar
• Yagita H, Okumura K, Nakauchi H: Molecular cloning of the murine homologue of CD2. Homology of the molecule to its human counterpart T11. Journal of Immu-nology 140: 1321–1326, 1988.
   Google Scholar
• Yagita SY, Chouaib S, Dupont B: A common pathway for T lymphocyte activation in-volving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determi-nants. Journal of Immunology 137: 1097–1100, 1986.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Nahmias A: Specific heterophile antibody from infectious mononucleosis serum. Proceedings of the Society of Experimental Biology and Medicine 124: 515–524, 1967.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Takeda N, Kasukawa R: Presence of Forssman-like and Hanganutziu-Deicher-like antibodies in Japanese sera. Japanese Journal of Experimental Medi-cine 51: 117–122, 1981.
   PubMed Web of Science ®Google Scholar
• Youinou P, Cledes J, Herve JP, Miossec P, Morrow WHVV: Low-affinity E-rosette-blocking in hemodialysis-treated patients in chronic renal failure. Clinical Immu-nology and Immunopathology 26: 423–431, 1983.
   PubMed Web of Science ®Google Scholar